medline.ch Onkologie

	Identifying expanding TCR clonotypes with a longitudinal Bayesian mixture model and their associations with cancer patient prognosis, metastasis-directed therapy, and VJ gene enrichment. Bioinformatics Swanson D, Sherry A, Haymaker C, Reuben A, Tang C. PMID: 42684031 [PubMed - as supplied by publisher]
	A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer. Oncoimmunology Wang CX, Luxardi G, Mori H, Maverakis EM, Merleev AA, Marusina AI, Borowsky AD, Parikh M, Riess JW, Moshiri A, Bazhenova L, Gubens M, Koczywas M, Butner JD, Huang J, Kim SK, Vick LV, Sun Y, Canter RJ, Murphy WJ, Daly ME, Kelly K, Monjazeb AM. PMID: 42684015 [PubMed - in process]
	Quantitative Apparent Diffusion Coefficient (ADC) Mapping as a Preoperative Biomarker for Tumor Grade and Myometrial Invasion in Endometrial Carcinoma. Ann Afr Med Ratre KK, Kumar M, Singh P, Kumari P. PMID: 42684014 [PubMed - as supplied by publisher]
	Residential location shapes initial prostate cancer care in Korea (2010-2020): A nationwide stage- and risk-stratified study. Investig Clin Urol Ko YH, Kim SW, Son NH. PMID: 42683859 [PubMed - in process]
	Predictors of active surveillance discontinuation in prostate cancer: Large Korean multicenter cohort study. Investig Clin Urol Choi J, Lee CU, Jeon SS, Byun SS, Joung JY, Ahn H, Cho JS, Park SW, Kwon DD, Ha US, Park JY, Kwon TG, Jo JK, Jeong CW, Kwak C, Prostate Cancer Study Group of the Korean Urological Oncology Society (KUOS). PMID: 42683858 [PubMed - in process]
	Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial. Investig Clin Urol Lee HW, Song G, Lee HH, Jung EH, Kim SY, Kim H, Park WS, Kwon J, Seo HK. PMID: 42683856 [PubMed - in process]
	Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis. Investig Clin Urol Kim JH, Lee SH, Song YS. PMID: 42683853 [PubMed - in process]
	Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer. Mol Oncol Kim A, Aslam M, Torruella E, Sony A, Rahman A, Smith S, de la Parra C, Sauane M. PMID: 42683785 [PubMed - as supplied by publisher]
	In Situ Peptide Assembly for Cancer Therapy. Angew Chem Int Ed Engl Liang G, Sun X, Ma Y, Xia T, Cheng X, Liang G. PMID: 42683778 [PubMed - as supplied by publisher]
	Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma. Korean J Radiol Huang PH, Ou HY, Tsang LC, Hsu HW, Lim WX, Huang TL, Weng CC, Lu Y, Hsu CC, Chen CL, Yu CY, Cheng YF. PMID: 42683641 [PubMed - indexed for MEDLINE]
	Multicenter Study of MRI Features in Uterine Myxoid Leiomyosarcoma: Revealing and Overcoming a Critical Pitfall in Current Consensus Criteria. Korean J Radiol Saida T, Kawamatsu N, Fujii S, Shibuki S, Kikkawa N, Nakai G, Himoto Y, Fukui H, Ueda T, Ohya A, Hiyama T, Uchikawa Y, Tsuboyama T, Nakajima T, Kido A. PMID: 42683640 [PubMed - indexed for MEDLINE]
	Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities. J Dtsch Dermatol Ges Rubatto M, Baggi A, Depenni R, Guida M, Ascierto PA, Queirolo P, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Zamparini M, Proietti I, Marconcini R, Botticelli A, Barbieri V, Alfieri S, Fargnoli MC, Occelli M, Fava P, Capacchione A, Comunanza V, Bossi P, Quaglino P. PMID: 42683634 [PubMed - as supplied by publisher]
	ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes. Am J Gastroenterol Mankaney G, Idos GE, Stoffel EM, Weiss JM, Shah S, Qayed E, Harnegie MP, Burke CA. PMID: 42683623 [PubMed - indexed for MEDLINE]
	Global Burden of Secondhand Smoke-Attributable ER-Negative Breast Cancer and Exploratory Immune-Metabolic Mediation Using Mendelian Randomization. Int J Womens Health Yang D, Shang F, Ma X, Zhang H, Ren X, Luan X, Wang J, Li Y, Wu T, Lv D, Yan Y, Liu J, Xu Y. PMID: 42683488 [PubMed]
	Balloon-Occluded Transarterial Chemoembolization for Hepatocellular Carcinoma: Technical Rationale, Current Evidence, and Future Directions. J Hepatocell Carcinoma Jia X, Chen Y, Cui X, Tian Y, Feng D, Wang W. PMID: 42683464 [PubMed]
	Bilateral Primary Breast Cancer: Current Evidence and Future Perspectives. Breast Cancer (Dove Med Press) Zhong H, Lu D, Zeng Y, Tu X, Zhang P, Xing T. PMID: 42683451 [PubMed]
	The neuro-immune-vascular landscape of lung cancer brain metastasis: insights from organoid models. Front Immunol Li J, Xu M, Wang L, Yu Y. PMID: 42683414 [PubMed - indexed for MEDLINE]
	Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective Study. Cancer Diagn Progn Nambara S, Ando K, Kawazoe T, Korehisa S, Tsuda Y, Nakanoko T, Oki E, Yoshizumi T. PMID: 42683411 [PubMed]
	CCN1 as a compartment-specific biomarker of active microenvironmental remodeling: evidence from bone repair, aging, inflammation, and cancer. Front Med (Lausanne) Tran AB, Ortiz-Hernandez GL. PMID: 42683406 [PubMed]
	Non-nutritive sweeteners, the gut microbiome, and tumor immunity: evidence hierarchy and a sucralose-centered translational model. Front Nutr Li J, Li DH, Liu YH, Zhang YP, Guo QQ, Zhu XJ, Wang YR, Shi YQ. PMID: 42683394 [PubMed]

Artikel 1 - 20 / 1969103

Seite 1 von 98456

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung